Literature DB >> 21745193

Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands.

C Bardelli1, A Amoruso, D Federici Canova, Lg Fresu, P Balbo, T Neri, A Celi, S Brunelleschi.   

Abstract

BACKGROUND AND
PURPOSE: Microparticles (MPs), small membrane-bound particles originating from different cell types during activation or apoptosis, mediate intercellular communication, exert pro-coagulant activity and affect inflammation and other pathophysiological conditions. Monocyte-derived MPs have undergone little investigation and, to our knowledge, have never been evaluated for their possible autocrine effects. Therefore, we assessed the ability of monocyte-derived MPs to stimulate human monocytes and monocyte-derived macrophages (MDM). EXPERIMENTAL APPROACH: MPs were generated from supernatants of human monocytes stimulated by the calcium ionophore A23187 (12 µM), and then characterized. Human monocytes and MDM of healthy donors were isolated by standard procedures. Cells were challenged by MPs or phorbol 12-myristate 13-acetate (PMA, used as standard stimulus), in the absence or presence of PPARγ agonists and antagonists. Superoxide anion production (measured spectrophotometrically), cytokine release (elisa), PPARγ protein expression (immunoblotting) and NF-κB activation (EMSA assay) were evaluated. KEY
RESULTS: Monocyte-derived MPs induced, in a concentration-dependent manner, oxygen radical production, cytokine release and NF-κB activation in human monocytes and macrophages, with lower effects than PMA. In both cell types, the PPARγ agonists rosiglitazone and 15-deoxy-Δ(12,14) -prostaglandin J(2) (15d-PGJ(2) ) inhibited MPs-induced stimulation and this inhibition was reversed by a PPARγ antagonist. In human monocyte/macrophages, MPs as well as rosiglitazone and 15d-PGJ(2) induced PPARγ protein expression. CONCLUSION AND IMPLICATIONS: In human monocyte/macrophages, monocyte-derived MPs exert an autocrine activation that was modulated by PPARγ ligands, inducing both pro-inflammatory (superoxide anion production, cytokine release and NF-κB activation) and anti-inflammatory (PPARγ expression) effects.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21745193      PMCID: PMC3315043          DOI: 10.1111/j.1476-5381.2011.01593.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

1.  Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway.

Authors:  M Mesri; D C Altieri
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

Review 2.  Membrane microparticles: two sides of the coin.

Authors:  Bénédicte Hugel; M Carmen Martínez; Corinne Kunzelmann; Jean-Marie Freyssinet
Journal:  Physiology (Bethesda)       Date:  2005-02

Review 3.  Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases.

Authors:  Jörg H W Distler; David S Pisetsky; Lars C Huber; Joachim R Kalden; Steffen Gay; Oliver Distler
Journal:  Arthritis Rheum       Date:  2005-11

4.  The release of microparticles by apoptotic cells and their effects on macrophages.

Authors:  J H W Distler; L C Huber; A J Hueber; C F Reich; S Gay; O Distler; D S Pisetsky
Journal:  Apoptosis       Date:  2005-08       Impact factor: 4.677

5.  Monocyte/macrophage-derived microparticles up-regulate inflammatory mediator synthesis by human airway epithelial cells.

Authors:  Chiara Cerri; Daniele Chimenti; Ilaria Conti; Tommaso Neri; Pierluigi Paggiaro; Alessandro Celi
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

6.  Differential mechanisms of microparticle transfer toB cells and monocytes: anti-inflammatory propertiesof microparticles.

Authors:  Barbara Köppler; Clemens Cohen; Detlef Schlöndorff; Matthias Mack
Journal:  Eur J Immunol       Date:  2006-03       Impact factor: 5.532

7.  Expression of functional NK1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-kappaB pathway.

Authors:  Claudio Bardelli; Gabriele Gunella; Federica Varsaldi; Pietro Balbo; Elisa Del Boca; Ilaria Seren Bernardone; Angela Amoruso; Sandra Brunelleschi
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

8.  A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.

Authors:  Gabriel Pascual; Amy L Fong; Sumito Ogawa; Amir Gamliel; Andrew C Li; Valentina Perissi; David W Rose; Timothy M Willson; Michael G Rosenfeld; Christopher K Glass
Journal:  Nature       Date:  2005-08-28       Impact factor: 49.962

9.  Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation.

Authors:  Ian Del Conde; Corie N Shrimpton; Perumal Thiagarajan; José A López
Journal:  Blood       Date:  2005-03-01       Impact factor: 22.113

10.  Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes.

Authors:  René J Berckmans; Rienk Nieuwland; Maarten C Kraan; Marianne C L Schaap; Desirée Pots; Tom J M Smeets; Augueste Sturk; Paul P Tak
Journal:  Arthritis Res Ther       Date:  2005-03-01       Impact factor: 5.156

View more
  18 in total

Review 1.  Microparticles and cardiovascular diseases.

Authors:  Christos Voukalis; Eduard Shantsila; Gregory Y H Lip
Journal:  Ann Med       Date:  2019-06-17       Impact factor: 4.709

Review 2.  Review: the Multiple Roles of Monocytic Microparticles.

Authors:  Ahmad Tarmizi Abdul Halim; Nur Azrah Fazera Mohd Ariffin; Maryam Azlan
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

Review 3.  Extracellular vesicles as mediators of vascular inflammation in kidney disease.

Authors:  Alexandra Helmke; Sibylle von Vietinghoff
Journal:  World J Nephrol       Date:  2016-03-06

Review 4.  Role of Extracellular Vesicles in the Pathogenesis of Vascular Damage.

Authors:  Fabrizio Buffolo; Silvia Monticone; Giovanni Camussi; Elena Aikawa
Journal:  Hypertension       Date:  2022-02-11       Impact factor: 9.897

5.  Acid sphingomyelinase is activated in sickle cell erythrocytes and contributes to inflammatory microparticle generation in SCD.

Authors:  Anthony O Awojoodu; Philip M Keegan; Alicia R Lane; Yuying Zhang; Kevin R Lynch; Manu O Platt; Edward A Botchwey
Journal:  Blood       Date:  2014-07-29       Impact factor: 22.113

6.  Microparticle-Induced Activation of the Vascular Endothelium Requires Caveolin-1/Caveolae.

Authors:  Allison M Andrews; Victor Rizzo
Journal:  PLoS One       Date:  2016-02-18       Impact factor: 3.240

Review 7.  Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke.

Authors:  Atsushi Mizuma; Midori A Yenari
Journal:  Front Neurol       Date:  2017-09-07       Impact factor: 4.003

Review 8.  Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression.

Authors:  Keshav Raj Paudel; Nisha Panth; Dong-Wook Kim
Journal:  Scientifica (Cairo)       Date:  2016-03-15

9.  Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus.

Authors:  Catalina Burbano; Juan Villar-Vesga; Janine Orejuela; Carlos Muñoz; Adriana Vanegas; Gloria Vásquez; Mauricio Rojas; Diana Castaño
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

10.  Paracrine Anti-inflammatory Effects of Adipose Tissue-Derived Mesenchymal Stem Cells in Human Monocytes.

Authors:  Maria I Guillén; Julia Platas; María D Pérez Del Caz; Vicente Mirabet; Maria J Alcaraz
Journal:  Front Physiol       Date:  2018-05-31       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.